Iovance Biotherapeutics Inc. (IOVA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Iovance Biotherapeutics I...

    NASDAQ: IOVA · Real-Time Price · USD
    2.49
    0.29 (13.18%)
    At close: Sep 05, 2025, 3:59 PM
    2.47
    -0.80%
    After-hours: Sep 05, 2025, 07:58 PM EDT

    Iovance Biotherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 115.69M 114.89M 231.73M 78.23M
    Short-Term Investments
    		 208.09M 164.98M 240.11M 426.18M
    Long-Term Investments
    		 n/a 66.43M 6.43M 91.59M
    Other Long-Term Assets
    		 6.73M 270K -178.25M 7.87M
    Receivables
    		 69.34M 151K n/a n/a
    Inventory
    		 51.52M 10.37M n/a n/a
    Other Current Assets
    		 12.38M 17.46M 7.27M n/a
    Total Current Assets
    		 457.02M 307.85M 479.12M 507.96M
    Property-Plant & Equipment
    		 164.28M 176.54M 178.25M 169.92M
    Goodwill & Intangibles
    		 282.4M 229.26M n/a n/a
    Total Long-Term Assets
    		 453.41M 472.5M 6.43M 269.38M
    Total Assets
    		 910.43M 780.35M 663.98M 777.33M
    Account Payables
    		 27.51M 33.12M 26.6M 27.38M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 12.9M 7.78M 12.59M 5.06M
    Other Current Liabilities
    		 69.04M 26.82M 20.3M 30.2M
    Total Current Liabilities
    		 122.34M 110.31M 91.48M 89.2M
    Long-Term Debt
    		 1M 1M 1M 1M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 77.68M 85.43M 72.86M 66.47M
    Total Liabilities
    		 200.02M 195.74M 164.34M 155.67M
    Total Debt
    		 58.26M 75.86M 85.45M 71.53M
    Common Stock
    		 13K 11K 8K 7K
    Retained Earnings
    		 -2.38B -2.01B -1.57B -1.17B
    Comprehensive Income
    		 -1.05M 2.53M -902K -601K
    Shareholders Equity
    		 710.4M 584.61M 499.64M 621.66M
    Total Investments
    		 208.09M 164.98M 240.11M 517.77M

    Add to Watchlist